Taken together, our data show that selective BTLA overexpression on circulating CD4+ T cells and HVEM suppression on circulating CD8+ T cells lead to increased coinhibitory signaling by BTLA, which contributes to peripheral T cell suppression in HCC patients. The gene discussed is CD8A; the disease is hepatocellular carcinoma.